Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Clin Breast Cancer ; 22(1): e1-e7, 2022 01.
Article in English | MEDLINE | ID: covidwho-1252588

ABSTRACT

BACKGROUND: The coronavirus disease 2019 pandemic is a global public health event. Wuhan used to be the epicenter of China and finally controlled the outbreak through city lockdown and many other policies. However, the pandemic and the prevention strategies had a huge impact on the medical care procedures for patients with breast cancer, leading to the delay or interruption of anticancer therapies. PATIENTS AND METHODS: To better serve patients with breast cancer under the premise of epidemic control, many strategies have been proposed and optimized in our center. One of the most important parts of these strategies is the promotion of telemedicine, including online consultation, online prescription, and drug mailing services. RESULTS: In keeping with the city and hospital policies, we have also introduced stricter ward management policies and more precise care. CONCLUSION: Here, we collected the diagnosis and treatment process of patients with breast cancer in our center during the coronavirus disease 2019 pandemic, which was found to be correlated to a reduction in chemotherapy-related myelosuppression and hepatic dysfunction, hoping to provide a reference for other cancer centers that may suffer from the similar situation.


Subject(s)
Breast Neoplasms/drug therapy , COVID-19/epidemiology , SARS-CoV-2 , Adult , Aged , Antineoplastic Agents/adverse effects , Bone Marrow/drug effects , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Chemical and Drug Induced Liver Injury/etiology , China/epidemiology , Female , Humans , Middle Aged , Telemedicine
SELECTION OF CITATIONS
SEARCH DETAIL